H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9

Futu NewsNov 19 19:31 · Ratings

Rani Therapeutics Advances in Biotherapeutics Market

TipRanksNov 19 11:54

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Immutep Ltd (OtherPRRUF)

TipRanksNov 18 10:10 · Ratings

Rani Therapeutics' Weight-Loss Drugs Can Serve Specific Needs -- Market Talk

WSJNov 16 00:59

Rani Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 14 21:27 · Announcements

Rani Therapeutics | 8-K: Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

SECNov 14 21:11